Latest filing published 07 Jan 2025 for Cartesian Therapeutics, Inc., €39k.
Filing timeline
BuySaleInsider track record
Metin Kurtoglu: trading record in brief
All filings by Metin Kurtoglu on record concern Cartesian Therapeutics, Inc. Over a trading history stretching from 2 January 2024 to 6 January 2025, the count stands at 24 filings.
The open-market record consists of 14 sales worth €2.4M, with no purchase. The rest of the record consists of 2 share grants and 8 option exercises. Since January 2025: no purchases and 2 sales on the market.
Most recently, on 7 January 2025, the filings show an open-market sale worth €40k in Cartesian Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Metin Kurtoglu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,417 shares@ US$16.721944.4% of flowCommon StockSEC:0001453687-25-000040:0
- 16,100 shares0Common StockSEC:0001453687-25-000018:0
- 10,763 shares@ US$1.4116.2% of flowCommon StockSEC:0001453687-24-000145:0
- 200 shares@ US$1.410.3% of flowCommon StockSEC:0001453687-24-000140:0
- 25,900 shares@ US$1.4139.0% of flowCommon StockSEC:0001453687-24-000132:0
- 1,531,000 shares0Common StockSEC:0001453687-24-000016:0
6 of 6 declarations
